4//SEC Filing
SCICLONE PHARMACEUTICALS INC 4
Accession 0000880771-17-000108
CIK 0000880771operating
Filed
Jun 13, 8:00 PM ET
Accepted
Jun 14, 4:50 PM ET
Size
8.8 KB
Accession
0000880771-17-000108
Insider Transaction Report
Form 4
Xie Lan
VP Finance China, CFO
Transactions
- Exercise/Conversion
Restricted Stock Unit
2017-06-12−1,000→ 18,000 total→ Common Stock (1,000 underlying) - Sale
Common Stock
2017-06-12$10.75/sh−1,000$10,750→ 0 total - Exercise/Conversion
Common Stock
2017-06-12+1,000→ 1,000 total
Footnotes (3)
- [F1]Granted under the Issuer's 2005 Equity Incentive Plan.
- [F2]Each restricted stock unit represents the right to receive, at settlement, one share of common stock.
- [F3]Vesting for such RSUs will occur 25% on March 16, 2016, 25% on March 16, 2017, 25% on March 16, 2018, and 25% on March 16, 2019, or on such later date thereafter as the Company's trading window opens, if it is not open on any of such dates, contingent upon the executive's continued employment.
Documents
Issuer
SCICLONE PHARMACEUTICALS INC
CIK 0000880771
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000880771
Filing Metadata
- Form type
- 4
- Filed
- Jun 13, 8:00 PM ET
- Accepted
- Jun 14, 4:50 PM ET
- Size
- 8.8 KB